Beta Carotene Tablets & Capsules Contract Manufacturing
KS Nutripharma® provides private-label and custom manufacturing for beta carotene tablets, capsules, softgels, gummies, powders, sachets, drops and liquid supplements, supported by our beta carotene ingredient portfolio spanning standard powder, beadlets, CWS microencapsulated powder and oil suspensions. Our R&D team connects the selected ingredient system with the appropriate dosage form, packaging and quality plan.
Manufacturing Capacity At a Glance
- ✓ OEM / Private Label Available— tablets, capsules, softgels, gummies, powders, drops and liquids under your brand
- ✓ MOQ from 1,000 finished retail units per SKU (powders and sachets); 3,000–5,000 units for tablets, capsules and softgels
- ✓ Lead Time: samples in 7–15 days; pilot batch 15–25 days; mass production 30–45 days
- ✓ Quality & Certifications: cGMP manufacturing; ISO 9001, ISO 22000, FSSC 22000 and HACCP; Halal and Kosher certified
- ✓ 7 Dosage Formats: tablets, capsules, softgels, gummies, powders, sachets, and liquids
- ✓ Request a Quote: initial project response within one business day
Beta Carotene Ingredient Sources
Beta-carotene is available from several production routes. The source you choose determines cost, label positioning and documentation requirements.
| Source | Characteristics |
| Blakeslea trispora fermentation | Natural-source beta carotene produced by fermentation; supports natural-origin positioning in markets that recognize fermented carotenoids as natural, with source and process documentation |
| Synthetic beta carotene | Nature-identical all-trans molecule; cost-efficient, highly consistent in assay and color value; the global market mainstream |
| Dunaliella salina algae | Natural premium source; algal extract with a carotenoid profile defined by the ingredient specification; available on request |
Source availability must be confirmed by product code. A “natural” claim requires source and production-process documentation, and the rules differ between destination markets.
Popular Commercial Strengths
| Product | Typical strength |
| Beta Carotene Softgel | 10,000 IU (≈6 mg beta-carotene, ≈3,000 mcg RAE) |
| Beta Carotene Softgel | 25,000 IU (≈15 mg beta-carotene, ≈7,500 mcg RAE) |
| Beta Carotene Capsule / Tablet | 15 mg |
| Mixed Carotenoid Formula | Custom |
Reference strengths commonly seen on retail products; IU appears on legacy labels or in specific markets — current US labels declare vitamin A activity in mcg RAE (1 mcg RAE = 2 mcg supplemental beta-carotene). Reference amounts only: final dosage depends on destination-market regulations, and higher-potency products require additional safety and label review.
Beta Carotene Dosage Forms and MOQs
| Dosage form | Typical MOQ (finished retail units/SKU) | Daily production capacity | Suitable for |
| Tablets | 3,000–5,000 | 12+ million units | Cost-efficient, high-volume products |
| Capsules | 3,000–5,000 | 5+ million units | Flexible powder and beadlet formulas |
| Softgels | 3,000–5,000 | 2+ million units | Oil-based beta carotene systems |
| Gummies | 5,000–10,000 | 2+ million units | Consumer-friendly product concepts |
| Powders and sachets | 1,000–3,000 | Bulk blending supported | Drink mixes and premixes |
| Drops and liquids | Typically 5,000–10,000, confirmed after review | High-volume filling supported | Liquid and measured-drop concepts |
Capacities shown are facility-wide outputs under standard production configurations. Actual project throughput, MOQ and lead time depend on formula, unit size, packaging, testing and line scheduling.
Beta-carotene is fat-soluble and is commonly formulated in an oil-based softgel system.
Softgel customization:
- 10%, 20% or 30% beta carotene oil-suspension options
- Carrier-oil options confirmed according to ingredient compatibility, allergen requirements and availability
- Target fill weight, softgel size and shape
- Shell color and opacity
- Bottle count and light-protective packaging
- Single-ingredient or carotenoid-combination formulas
The oil carrier, viscosity, sedimentation behavior, fill compatibility and stability must be reviewed before production.
Capsules offer formulation flexibility and may reduce development complexity for selected beta carotene powder and beadlet systems.
Capsule customization:
- Capsule size and shell material (gelatin or vegetarian HPMC)
- Capsule and imprint color
- Target serving size customized according to the ingredient specification, target population and destination-market requirements
- Powder or beadlet fill
- Single-ingredient or combination formula
- Bottle count, desiccant and induction seal
- Private-label packaging
Suitable ingredient systems:
- Standard beta carotene powder (5%–96%)
- Beta carotene beadlets (1%, 10%)
- Premixed carotenoid systems
Capsule feasibility depends on the active concentration, carrier, bulk density, flow properties and target serving size.
Beta carotene tablets provide an efficient format for single-ingredient products, multivitamins and combination formulas.
Tablet customization:
- Target potency customized according to the ingredient specification, serving size, target population and destination-market requirements
- Tablet size and shape: round, oval or oblong formats
- Coated or uncoated tablets (film coating recommended for light protection)
- Single-ingredient or combination formulas
- Bottle count and bulk packaging
- Color and appearance options
- Vegetarian and allergen requirements
- Market-specific label documentation
Ingredient options — depending on technical suitability:
- Standard beta carotene powder (5%–96%, 80 mesh)
- Beta carotene beadlets (1%, 10%)
- Fermentation-derived or synthetic-source materials
The selected ingredient must be assessed for potency, particle size, flowability, compressibility, content uniformity and stability.
Powder formats may be suitable for drink mixes, nutritional sachets and premix concepts.
Available options:
- CWS microencapsulated powder (1%, 10%)
- Beta carotene beadlets (1%, 10%)
- Single-serving sachets and stick packs
- Bulk powder packaging
- Flavored drink-mix concepts
- Carotenoid combination powders
Development considerations include dispersibility, color, flavor compatibility, oxygen exposure and packaging; opaque or metallized sachet material is recommended for light-sensitive carotenoids. For dedicated food and beverage coloring projects, see our beverage colorant solution
Beta carotene gummies provide a differentiated consumer format but require careful assessment of processing temperature, color, flavor and stability.
Gummy customization:
- Target beta carotene serving amount, set per project
- Flavor and aroma; shape and size
- Gummy color — beta carotene contributes a natural-looking orange tone; further color customization available
- Sweetener system; pectin or gelatin system; sugar-free concept evaluation
- Bottle or pouch packaging
- Combination formulas
CWS microencapsulated grades may be evaluated for improved dispersibility and ingredient protection in gummy systems. Active retention must be confirmed through pilot production and stability testing.
Liquid formats may be developed using an appropriate dispersed, emulsified or oil-based beta carotene system. Oil-based drop concepts may be developed using a suitably diluted and validated beta carotene oil system; concentration, homogeneity, dose delivery and sedimentation must be confirmed in the finished product.
Liquid customization:
- Target concentration and measured-dose format
- Carrier and emulsion system
- Flavor and color
- Bottle size; dropper or measured-dose closure
- Light-protective packaging
Final feasibility depends on dispersibility, sedimentation, pH, temperature, packaging and proposed shelf life.
Popular Beta Carotene Formula Concepts
The concepts below are development directions, not finished formulas with fixed doses or health claims. Final composition and potency are confirmed through feasibility review and destination-market regulatory assessment. For complete reference formulations with composition tables, see our natural beta carotene supplements page
Ingredient directions: beta carotene, lutein, zeaxanthin, vitamin E, zinc. Recommended formats: softgel, capsule or tablet. Positioned as nutritional support — no disease prevention or treatment claims.
Ingredient directions: beta carotene, astaxanthin, collagen, vitamin C. Recommended formats: softgel, gummy or powder sachet. Collagen typically requires a larger serving amount than carotenoids — dual-format or powder formats may be evaluated.
Ingredient directions: beta carotene, lycopene, mixed tocopherols, CoQ10. Recommended format: softgel. Vitamin E and tocopherol systems are declared separately, not under a single IU figure.
Ingredient directions: low-dose beta carotene (as a vitamin A source), folate, DHA, iron. Recommended formats: softgel, capsule or gummy. Prenatal products are subject to destination-market regulatory and safety review; the form and level of vitamin A are critical formulation decisions confirmed during that review.
| Your goal | Recommended format |
| Lowest cost | Tablets |
| Premium positioning | Softgels |
| Children’s products | Gummies |
| Drink mixes | Sachets |
| Eye-health formula | Softgels |
Choose tablets when: unit cost and production scale are priorities · the formula contains additional vitamins or minerals · a compact retail format is required · the ingredient is suitable for compression.
Choose capsules when: formula flexibility is important · powder or beadlet ingredients are preferred · the brand wants a straightforward dosage form · tablet compression is unsuitable.
Choose softgels when: an oil-based beta carotene system is preferred · the product contains other fat-soluble ingredients · light and oxygen protection can be built into the package · a premium product format is required.
Choose gummies when: consumer experience and flavor are priorities · the target serving size is technically achievable · processing and shelf-life stability have been evaluated.
Choose powders or liquids when: the product is positioned as a drink mix or drops · flexible serving formats are required · dispersibility and color are part of the product experience.
| Ingredient system | Available potency | Recommended applications |
| Standard powder | 5%–96%* | Tablets, hard capsules and premixes |
| CWS microencapsulated powder | 1%, 10% | Gummies, drink powders, sachets and premixes |
| Beta carotene beadlets | 1%, 10% | Tablets, hard capsules and premixes |
| Oil suspension | 10%, 20%, 30% | Softgels and validated oil-based liquids |
*Exact potency and source availability must be confirmed for each project. Fermentation-derived and synthetic-source options may be available; a “natural” claim requires separate source and process documentation.
Beta carotene formulas require responsible dose, target-population and claim assessment. High-dose beta carotene supplementation has been associated with increased risk in current smokers, former smokers and people exposed to asbestos. Accordingly:
- High-dose concepts require additional review
- Risk populations must be considered
- Food intake and supplement evidence should not be treated as equivalent
- Disease-prevention or treatment claims must not be used
- Tanning supplements must not be presented as a replacement for sunscreen
- Final claims must be supported and reviewed for the target market
The brand owner remains responsible for final legal approval of the product and label.
Beta carotene is sensitive to light, oxygen, heat and the surrounding formula. Our R&D assessment may consider:
- Ingredient source and standardized potency
- Carrier and microencapsulation system
- Particle size and flowability
- Compatibility with other ingredients
- Processing temperature
- pH and mineral content
- Content uniformity
- Disintegration or dissolution
- Packaging protection
- Proposed storage conditions
- Shelf-life verification
Finished-product performance must be confirmed against an agreed formula, process and quality specification.
Our R&D team evaluates each project according to formula compatibility, manufacturing feasibility and target-market requirements. Customization may include:
- Beta carotene source: synthetic or fermentation-derived; specialty natural sources (e.g., Dunaliella salina) on request
- Product form matched to your application:emulsion, oil suspension, crystal / high-content powder, standard powder, microcapsule CWS powder or beadlets
- Powder color customization: orange, pink, red and other shades adjusted to your application, dosage form and brand color system
- Target potency:1–15 mg beta-carotene per serving (≈1,670–25,000 IU provitamin A), assessed against destination-market limits
- Dosage form: tablets, capsules, softgels, gummies, powders or liquids
- Combination formulas: vitamin A, vitamin C, vitamin E, lutein, zeaxanthin, lycopene, astaxanthin or bilberry — subject to compatibility and stability assessment
- Capsule shell, carrier oil and excipient selection
- Flavor, color and sweetener options
- Vegetarian, vegan, non-GMO or allergen-free requirements
- Bottle, blister, pouch, sachet and bulk packaging
- Label and packaging review support
- Market-specific documentation
Application-based form and color customization: the product form — emulsion, oil suspension, crystal, standard powder, microcapsule powder or beadlets — is selected or developed around your application (tablets, softgels, gummies, beverages or premixes), and the powder shade can be customized across orange, pink and red tones to match your brand’s color system. Custom emulsions and color shades are confirmed during formula feasibility review.
Final ingredient options depend on availability, technical assessment and applicable regulations.
1. Market and Product Brief
Define the target market, consumer group, positioning, dosage form, serving size and price range.
2. Ingredient Verification
Confirm source, potency, carrier, certifications and supporting documentation.
3. Safety and Regulatory Review
Assess target population, total vitamin A contribution, claims, warnings and market-specific requirements.
4. Formulation Feasibility
Review ingredient compatibility, serving size, processing conditions and packaging.
5. Sample Development
Prepare a laboratory sample for appearance, taste, handling and preliminary technical evaluation.
6. Pilot Production
Confirm process transfer, uniformity, physical performance and packaging compatibility.
7. Stability Program
Establish applicable assay, appearance, microbiological, physical and packaging requirements.
8. Commercial Production
Manufacture and release the finished product according to the approved specification and quality plan.
KS Nutripharma combines scalable production capacity with flexible entry quantities.
Factory Infrastructure
- 19+ years of manufacturing experience
- 81,000+ m² GMP-compliant facility
- 2 dedicated R&D centers
- 12 automated production lines
- 260+ professionals
- 7 international certifications
- 500+ brands served
- Products supplied to 60+ export markets
Daily Production Capacity
| Dosage form | Daily capacity |
| Tablets | 12+ million units |
| Capsules | 5+ million units |
| Softgels | 2+ million units |
| Gummies | 2+ million units |
| Powders | Bulk blending supported |
| Liquids | High-volume filling supported |
Actual output and lead time depend on formula complexity, packaging, material availability and production scheduling.
Flexible MOQs
| Dosage form | Typical MOQ per SKU |
| Capsules | 3,000–5,000 units |
| Tablets | 3,000–5,000 units |
| Softgels | 3,000–5,000 units |
| Gummies | 5,000–10,000 units |
| Powders and sachets | 1,000–3,000 units |
| Liquids | Typically 5,000–10,000 units, confirmed after review |
MOQs are indicative and may change according to formula complexity, packaging, ingredient sourcing and testing requirements.
Standard Lead Times
- Sampling: 7–15 days
- Pilot batch: 15–25 days
- Mass production: 30–45 days
- Rush options: Subject to ingredient availability and production scheduling
Our facility operates under an international quality and food-safety framework covering the following certification programs:
- cGMP— dietary supplement GMP compliance (21 CFR Part 111 framework)
- ISO 9001— quality management
- ISO 22000 / FSSC 22000— food safety management
- HACCP— hazard analysis and critical control points
- Halalcertification
- Koshercertification
- FDA facility registration(United States)
Certificate scope, registration numbers and validity dates are provided on request and can be shared under NDA during project evaluation.
Market compliance support:
- United States:beta-carotene is a color additive exempt from certification (21 CFR 73.95) and a lawful dietary ingredient under DSHEA; labels declare vitamin A activity in mcg RAE.
- European Union:beta-carotene is an approved food additive (E 160a); vitamin A claims follow the NRV of 800 mcg RE under Regulation (EU) No 1169/2011.
- Label conversion guidance:1 mcg RAE = 2 mcg supplemental beta-carotene; 15 mg beta-carotene ≈ 25,000 IU provitamin A.
- Cautionary labeling:high-dose beta-carotene supplements (≥20 mg/day) are not recommended for smokers; we support appropriate warning statements for affected markets.
Each project is manufactured according to an agreed product specification and quality plan. Available documentation may include:
- Product specification and typical COA for the selected raw material grade
- Ingredient documentation (including source declaration: synthetic or Dunaliella salina)
- Batch documentation and Certificate of Analysis per production lot
- Allergen and dietary information
- Stability or shelf-life documentation, where applicable
- Manufacturing and certification documents
- Export documentation for supported markets
Standard testing items (per agreed specification):
- Identification:UV-Vis absorbance ratio (A455/A483) and HPLC retention-time match against reference standard
- Assay:beta-carotene content by HPLC / UV-Vis
- Physical:loss on drying, sieve analysis (powder grades)
- Heavy metals:lead, arsenic, cadmium, mercury
- Microbiology:total plate count, yeast and mold, coliforms, coli, Salmonella
- Oil-based forms:peroxide value and acid value
- Third-party verification:SGS, Intertek or Eurofins testing available on request
Tier-1 Raw Material Partnerships — Formulas built on beta carotene from dsm-firmenich, BASF, NHU and other leading producers, with full documentation and traceability.
Scalable Manufacturing — Move from pilot quantities to high-volume production without changing manufacturing partners.
Dedicated R&D Support — Two R&D centers support feasibility assessment, sample development and production transfer.
Multiple Dosage Forms — Develop tablets, capsules, softgels, gummies, powders and liquids through one manufacturing partner.
Flexible Entry Quantities — MOQ options support both market testing and established retail programs.
Export Experience — We have supported more than 500 brands across over 60 export markets.
Defined Project Timelines — Receive clear milestones for sampling, pilot production and commercial manufacturing.
| Format | Typical MOQ (finished retail units/SKU) |
| Tablets | 3,000–5,000 |
| Capsules | 3,000–5,000 |
| Softgels | 3,000–5,000 |
| Gummies | 5,000–10,000 |
| Powders and sachets | 1,000–3,000 |
| Drops and liquids | Typically 5,000–10,000, confirmed after review |
Standard lead times:
- Sample development: 7–15 days
- Pilot batch: 15–25 days
- Mass production: 30–45 days
Rush options: subject to material availability and production scheduling
Find the Right Beta Carotene Dosage Form
Tell us your target consumers, desired formula, dosage form, order quantity and launch market. Our team will evaluate appropriate ingredient systems and recommend a manufacturing path, with an initial project response within one business day.
Primary CTA: Request a Formula Consultation Secondary CTA: Download a Sample COA
Recommended RFQ fields:
- Name and business email
- Company and website
- Country and target market
- Preferred dosage form
- Formula concept
- Beta carotene source preference
- Target serving amount
- Additional ingredients
- Initial order quantity
- Packaging requirements
- Required certifications
- Target launch date
Synthetic beta carotene is a nature-identical all-trans molecule — cost-efficient and highly consistent. Natural-source options include Blakeslea trispora fermentation-derived beta carotene and Dunaliella salina algal extract, which support natural-origin positioning where source and process documentation is provided and market rules allow.
Softgels protect oil-based systems inside a sealed shell; beadlets and CWS microencapsulated powders protect dry formats through their wall systems. Final stability is verified per formula and packaging through stability evaluation.
The appropriate format depends on the ingredient system, potency, combination ingredients, consumer preference, cost and target market. Softgels are often evaluated for oil systems, while capsules and tablets may use powders or beadlets.
Yes — this is a common eye-nutrition combination. Compatibility, serving size, stability and destination-market rules are reviewed per project. See our natural beta carotene supplements page for complete reference formulations.
Yes. AREDS2-pattern-inspired concepts can be developed and adapted to destination-market rules, including beta-carotene-free versions for products that may be used by smokers. Such products are positioned as nutritional support and must not be marketed as treating or preventing age-related eye disease.
The United States declares vitamin A activity in mcg RAE on Nutrition and Supplement Facts labels; the European Union uses mcg RE. Other markets vary. Our team supports compliant conversion and declaration for your destination market.
Light- and oxygen-protective packaging: amber or opaque bottles with desiccant and induction seal, high-barrier blister packs, metallized sachets and secondary cartons. The final configuration is confirmed with the formula and stability plan.
Yes, at appropriate potencies. Children’s products are subject to stricter, market-specific upper levels for vitamin A; age-band potency is set during regulatory review.
Natural-origin options may be available. The ingredient source, carrier and documentation must be reviewed before making a natural claim.
Yes. Our 10%, 20% and 30% oil suspensions can be evaluated for softgel formulations according to potency, carrier and stability requirements.
Current US labels declare vitamin A activity in mcg RAE: 15 mg of supplemental beta carotene provides approximately 7,500 mcg RAE (1 mcg RAE = 2 mcg supplemental beta-carotene). IU values such as 25,000 IU appear only on legacy labels or in specific markets.
Yes. CWS microencapsulated grades may be evaluated for gummy systems, subject to processing-temperature assessment, flavor, color and stability testing in the actual formula.
Yes. The serving amount is evaluated according to ingredient potency, dosage form, safety, target population and target-market requirements.
Requested potency can be evaluated, but higher-dose products require additional safety, target-population and regulatory review. Approval is not guaranteed.
- NIH Office of Dietary Supplements. Vitamin A and Carotenoids — Fact Sheet for Health Professionals.https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
- EFSA Panel on Food Additives and Nutrient Sources. Scientific Opinion on the re-evaluation of mixed carotenes (E 160a (i)) and beta-carotene (E 160a (ii)) as food additives.EFSA Journal 2012;10(3):2593.
- US Food and Drug Administration. Guidance for Industry: Converting Units of Measure for Folate, Niacin, and Vitamins A, D, and E on the Nutrition and Supplement Facts Labels.August 2019.
- Linus Pauling Institute, Oregon State University. Carotenoids — Micronutrient Information Center.https://lpi.oregonstate.edu/mic/dietary-factors/phytochemicals/carotenoids
- The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.New England Journal of Medicine 1994;330:1029–1035.
- Omenn GS, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease (CARET).New England Journal of Medicine 1996;334:1150–1155.
- Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial.JAMA 2013;309(19):2005–2015.
- US Code of Federal Regulations. 21 CFR 73.95 — β-Carotene; color additives exempt from batch certification.
